ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

AMPE Ampio Pharmaceuticals Inc

0,62
0,00 (0,00%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,62 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,62 0,62
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.4.202420:33PRNUSAmpio Pharmaceuticals Received Audit Opinion with Going..
25.3.202422:00PRNUSAmpio Announces Voluntary Delisting and SEC Deregistration
05.3.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
28.2.202421:49EDGAR2Form 8-K - Current report
28.2.202421:48EDGAR2Form S-8 POS - Securities to be offered to employees in..
28.2.202421:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
28.2.202421:46EDGAR2Form POS AM - Post-Effective amendments for registration..
28.2.202421:45EDGAR2Form RW - Registration Withdrawal Request
15.2.202415:31EDGAR2Form 8-K - Current report
14.2.202423:45PRNUSAmpio Provides Update on Results from Pre-IND Enabling..
25.1.202422:31EDGAR2Form 8-K - Current report
25.1.202422:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24.1.202423:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11.1.202422:20EDGAR2Form 8-K - Current report
11.1.202422:15PRNUSAmpio Provides Litigation Update - Reports Settlement in..
21.12.202322:25EDGAR2Form S-1 - General form for registration of securities under..
14.11.202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202314:30EDGAR2Form 8-K - Current report
31.10.202314:00PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
27.10.202320:10EDGAR2Form 8-K - Current report
06.10.202320:56EDGAR2Form 8-K - Current report
05.10.202322:30PRNUSAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO..
04.10.202322:15EDGAR2Form 8-K - Current report
26.9.202315:15PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
22.9.202322:30EDGAR2Form 8-K - Current report
18.9.202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
31.8.202322:19EDGAR2Form 8-K - Current report
31.8.202312:30PRNUSAmpio Pharmaceuticals Announces Reverse Stock Split
15.8.202322:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
08.8.202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.7.202317:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05.7.202322:37EDGAR2Form 8-K - Current report
26.5.202322:40PRNUSAmpio Pharmaceuticals Announces Series D Preferred Stock..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock